Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosulfan blue for sentinel lymph node mapping in early breast cancer
CTR20210602Phase 3Completed
- Sponsor
- Guangdong Xinghao Pharmaceutical
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isosulfan blue in breast cancer, sponsored by Guangdong Xinghao Pharmaceutical. Started Mar 2021; status: completed.
02
Drugs
isosulfan blue
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20210602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210602.